The Pennant Group, Inc. (NASDAQ:PNTG – Get Free Report) rose 4.5% during mid-day trading on Tuesday . The company traded as high as $31.35 and last traded at $31.35. Approximately 58,978 shares were traded during trading, a decline of 70% from the average daily volume of 199,725 shares. The stock had previously closed at $30.01.
Analyst Upgrades and Downgrades
Several research analysts have recently weighed in on PNTG shares. Oppenheimer boosted their price objective on shares of The Pennant Group from $34.00 to $37.00 and gave the company an “outperform” rating in a report on Friday, November 8th. Truist Financial boosted their target price on shares of The Pennant Group from $34.00 to $38.00 and gave the company a “hold” rating in a research note on Monday, October 7th. Stephens restated an “overweight” rating and issued a $40.00 price target on shares of The Pennant Group in a research note on Wednesday, October 9th. Finally, Royal Bank of Canada lifted their price objective on The Pennant Group from $26.00 to $38.00 and gave the stock an “outperform” rating in a report on Wednesday, October 23rd.
View Our Latest Research Report on PNTG
The Pennant Group Price Performance
Institutional Trading of The Pennant Group
A number of hedge funds and other institutional investors have recently bought and sold shares of PNTG. FMR LLC grew its stake in shares of The Pennant Group by 51.3% during the 3rd quarter. FMR LLC now owns 2,528,512 shares of the company’s stock valued at $90,268,000 after acquiring an additional 856,838 shares during the period. Atom Investors LP bought a new position in shares of The Pennant Group in the third quarter worth approximately $3,981,000. Federated Hermes Inc. increased its stake in shares of The Pennant Group by 600.0% in the second quarter. Federated Hermes Inc. now owns 54,045 shares of the company’s stock worth $1,253,000 after purchasing an additional 46,324 shares in the last quarter. Renaissance Technologies LLC raised its position in shares of The Pennant Group by 17.1% during the 2nd quarter. Renaissance Technologies LLC now owns 267,300 shares of the company’s stock valued at $6,199,000 after purchasing an additional 39,000 shares during the period. Finally, Barclays PLC raised its position in shares of The Pennant Group by 375.0% during the 3rd quarter. Barclays PLC now owns 49,101 shares of the company’s stock valued at $1,753,000 after purchasing an additional 38,763 shares during the period. Hedge funds and other institutional investors own 85.88% of the company’s stock.
The Pennant Group Company Profile
The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
Further Reading
- Five stocks we like better than The Pennant Group
- The How and Why of Investing in Gold Stocks
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- Why Invest in High-Yield Dividend Stocks?
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- How to Effectively Use the MarketBeat Ratings Screener
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.